loxo oncology inc
(LOXO:Consolidated Issue listed on NASDAQ Global Market)
Joshua H. Bilenker M.D.
Founder, Chief Executive Officer, President and Director, Loxo Oncology, Inc.
|Age||Total Calculated Compensation||This person is connected to 85 board members in 7 different organizations across 8 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Joshua H. Bilenker, also known as Josh, MD, is an Operating Partner at Aisling Capital LLC. He previously served as a Principal at the firm. Dr. Bilenker has been the Chief Executive Officer and President of Loxo Oncology, Inc., which he founded May 2013. He served as the Chief Financial Officer and Principal Accounting Officer of Loxo Oncology, Inc. Previously, he served as a Medical Officer in the Office of Oncology Drug Products at the United States Food and Drug ...
One Landmark SquarePhone: 203-653-3880
Stamford, Connecticut 06901
Board Members Memberships*
Director and Chairman of Nominating & Corporate Governance Committee
Former Director and Member of Audit Committee
Founder, Chief Executive Officer, President and Director
Johns Hopkins School of Medicine
|There is no Competitor Compensation data available.|